Peripheral Nerve Stimulation for Treatment of Sacroiliac Joint Pain
Unknown statusNot applicableNCT05357300
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Prospective randomized controlled study, primary objective: Pain reduction in patients with chronic Sacroiliac joint pain after therapy either with Peripheral Nerve Stimulation or with best medical treatment. Randomization 4:3 to operative (PNS=Peripheral Nerve Stimulation) arm or conservative (BMT= Best Medical Treatment) arm with crossover possibility for the BMT group after 6 months.
Study details
- Official title
- Peripheral Nerve Stimulation for Treatment of Chronic Therapy-refractory Sacroiliac Joint Pain
- Conditions
- Sacroiliac Joint Pain
- Interventions
- Device: Peripheral Nerve Stimulation
- Sponsor
- PD Dr. med. Simon Bayerl
- Organization
- Charite University, Berlin, Germany
- Start date
- 2022-04-26
- Primary completion
- 2025-04
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Germany
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Subject is at least 18 years old * Subject with chronic sacroiliac joint pain refractory to conservative treatment * Subject with NRS of at least 60/100 * Subject with temporary pain reduction of at least 50% (NRS) after fluoroscopy guided SIJ infiltration * Subject received conservative treatment for at least three months including physiotherapy and pain medication * Subject is able to understand the study and Impulse generator programming Exclusion Criteria: * Pregnancy * Subject is under age * Acute traumatic injury of the ISG * Active inflammation or neoplastic infiltration of the SIJ * Neoplastic diseases of the spine * Spinal surgery within the last three months * The SIJ pain is not the leading symptom * Contraindication for Neuromodulation Device (severe psychiatric disease, severe coagulation disorder, acute infection, active autoimmune disease with immunosupression)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05357300